Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort

Antonio Di Biagio, Roberta Prinapori, Diana Giannarelli, Franco Maggiolo, Simona Di Giambenedetto, Vanni Borghi, Giovanni Penco, Paola Cicconi, Daniela Francisci, Gaetana Sterrantino, Alessia Zoncada, Laura Monno, Amedeo Capetti, Andrea Giacometti

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Duration of first-line antiretroviral therapy with tenofovir and emtricitabine combined with atazanavir/ritonavir, efavirenz or lopinavir/ritonavir in the Italian ARCA cohort'. Together they form a unique fingerprint.

Medicine & Life Sciences